Baker / Tisch Capital (GP), LLC Insider Trading Transactions
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX).
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, BCRX, GHDX, INCY, NRGN, SGEN, GEVA, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2011 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | J | 0.00 | 83,119 | 0 | 1,306 | 84.4 K to 1.3 K (-98.45 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 1.18 | 60 | 71 | 12,679 | 12.7 K to 12.7 K (-0.47 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 1.19 | 142 | 169 | 12,739 | 12.9 K to 12.7 K (-1.10 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 1.30 | 91 | 118 | 12,881 | 13 K to 12.9 K (-0.70 %) |
Oct 29 2010 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 1.28 | 37 | 47 | 12,972 | 13 K to 13 K (-0.28 %) |
Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.86 | 3,820 | 56,768 | 159,739 | 163.6 K to 159.7 K (-2.34 %) |
Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.71 | 4,829 | 71,043 | 163,559 | 168.4 K to 163.6 K (-2.87 %) |
Sep 23 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.94 | 12,974 | 193,870 | 168,388 | 181.4 K to 168.4 K (-7.15 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.00 | 1,239 | 17,344 | 181,362 | 182.6 K to 181.4 K (-0.68 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.00 | 638 | 8,932 | 182,601 | 183.2 K to 182.6 K (-0.35 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.08 | 4,041 | 56,903 | 183,239 | 187.3 K to 183.2 K (-2.16 %) |
Aug 11 2010 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Sell | S | 14.09 | 2,629 | 37,036 | 187,280 | 189.9 K to 187.3 K (-1.38 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.10 | 7 | 43 | 84,425 | 84.4 K to 84.4 K (+0.01 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.08 | 39 | 237 | 84,418 | 84.4 K to 84.4 K (+0.05 %) |
May 26 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.08 | 40 | 243 | 84,379 | 84.3 K to 84.4 K (+0.05 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 110 | 660 | 84,339 | 84.2 K to 84.3 K (+0.13 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.98 | 73 | 437 | 84,229 | 84.2 K to 84.2 K (+0.09 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.99 | 52 | 312 | 84,156 | 84.1 K to 84.2 K (+0.06 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.84 | 12 | 70 | 84,104 | 84.1 K to 84.1 K (+0.01 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.87 | 37 | 217 | 84,092 | 84.1 K to 84.1 K (+0.04 %) |
May 20 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 98 | 588 | 84,055 | 84 K to 84.1 K (+0.12 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.46 | 679 | 3,706 | 83,957 | 83.3 K to 84 K (+0.82 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.46 | 157 | 858 | 83,278 | 83.1 K to 83.3 K (+0.19 %) |
May 15 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.45 | 160 | 872 | 83,121 | 83 K to 83.1 K (+0.19 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.86 | 219 | 1,283 | 82,961 | 82.7 K to 83 K (+0.26 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.92 | 298 | 1,765 | 82,742 | 82.4 K to 82.7 K (+0.36 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.73 | 173 | 991 | 82,444 | 82.3 K to 82.4 K (+0.21 %) |
May 11 2009 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.72 | 321 | 1,836 | 82,271 | 82 K to 82.3 K (+0.39 %) |
May 20 2009 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.72 | 35,253 | 342,659 | 400,898 | 365.6 K to 400.9 K (+9.64 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.82 | 10 | 178 | 194,161 | 194.2 K to 194.2 K (+0.01 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 18.00 | 44 | 792 | 194,151 | 194.1 K to 194.2 K (+0.02 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.88 | 4 | 72 | 194,107 | 194.1 K to 194.1 K (0.00 %) |
May 22 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 17.98 | 32 | 575 | 194,103 | 194.1 K to 194.1 K (+0.02 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.36 | 22 | 426 | 194,071 | 194 K to 194.1 K (+0.01 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.51 | 95 | 1,853 | 194,049 | 194 K to 194 K (+0.05 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.67 | 67 | 1,318 | 193,954 | 193.9 K to 194 K (+0.03 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.54 | 96 | 1,876 | 193,887 | 193.8 K to 193.9 K (+0.05 %) |
May 11 2009 | GHDX | GENOMIC HEALTH INC | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 19.53 | 32 | 625 | 193,791 | 193.8 K to 193.8 K (+0.02 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.89 | 835 | 3,244 | 17,241 | 18.1 K to 17.2 K (-4.62 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 3.86 | 2,157 | 8,335 | 18,076 | 20.2 K to 18.1 K (-10.66 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.12 | 2,065 | 8,514 | 20,233 | 22.3 K to 20.2 K (-9.26 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.30 | 402 | 1,729 | 22,298 | 22.7 K to 22.3 K (-1.77 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.50 | 2,975 | 13,400 | 22,700 | 25.7 K to 22.7 K (-11.59 %) |
Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 4.45 | 1,651 | 7,353 | 25,675 | 27.3 K to 25.7 K (-6.04 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 25,000 | 280,450 | 470,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 20,000 | 224,370 | 294,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 8,000 | 89,748 | 274,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 24,000 | 269,244 | 266,000 | |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.16 | 64 | 138 | 139,615 | 139.6 K to 139.6 K (+0.05 %) |
Mar 05 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.14 | 98 | 210 | 139,551 | 139.5 K to 139.6 K (+0.07 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 81,000 | 908,658 | 242,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 21,000 | 235,589 | 161,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 31,000 | 347,774 | 140,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 78,000 | 875,043 | 109,000 | |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.17 | 164 | 356 | 139,453 | 139.3 K to 139.5 K (+0.12 %) |
Mar 02 2009 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 2.14 | 179 | 382 | 139,289 | 139.1 K to 139.3 K (+0.13 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.26 | 8 | 66 | 72,035 | 72 K to 72 K (-0.01 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 9,380 | 76,670 | 72,043 | 81.4 K to 72 K (-11.52 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.11 | 1,782 | 14,444 | 81,423 | 83.2 K to 81.4 K (-2.14 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.17 | 453 | 3,702 | 83,205 | 83.7 K to 83.2 K (-0.54 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.16 | 2,411 | 19,682 | 83,658 | 86.1 K to 83.7 K (-2.80 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.46 | 9,153 | 77,429 | 86,069 | 95.2 K to 86.1 K (-9.61 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.47 | 980 | 8,300 | 95,222 | 96.2 K to 95.2 K (-1.02 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 9.03 | 102 | 921 | 96,202 | 96.3 K to 96.2 K (-0.11 %) |
Feb 06 2009 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 8.01 | 3,574 | 28,615 | 96,304 | 99.9 K to 96.3 K (-3.58 %) |
Oct 21 2008 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | J | 2.74 | 98 | 269 | 75,075 | 75 K to 75.1 K (+0.13 %) |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | C | 0.00 | 4,812 | 0 | 0 | |
Nov 13 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | C | 0.00 | 125,112 | 0 | 335,668 | 210.6 K to 335.7 K (+59.42 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 31,000 | 347,820 | 406,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 52,000 | 583,440 | 52,000 | |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.60 | 1,637 | 5,886 | 139,110 | 137.5 K to 139.1 K (+1.19 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.62 | 290 | 1,049 | 137,473 | 137.2 K to 137.5 K (+0.21 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.56 | 1,535 | 5,470 | 137,183 | 135.6 K to 137.2 K (+1.13 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.60 | 93 | 334 | 135,648 | 135.6 K to 135.6 K (+0.07 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.33 | 896 | 2,985 | 135,555 | 134.7 K to 135.6 K (+0.67 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.33 | 543 | 1,810 | 134,659 | 134.1 K to 134.7 K (+0.40 %) |
Dec 19 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 3.15 | 62 | 195 | 134,116 | 134.1 K to 134.1 K (+0.05 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.98 | 49 | 48 | 27,326 | 27.3 K to 27.3 K (+0.18 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 0.91 | 207 | 189 | 27,277 | 27.1 K to 27.3 K (+0.76 %) |
Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 1.00 | 2,028 | 2,028 | 27,070 | 25 K to 27.1 K (+8.10 %) |
Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Option Exercise | P | 11.14 | 998 | 11,118 | 998 | |
Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 11.14 | 3,990 | 44,449 | 95,646 | 91.7 K to 95.6 K (+4.35 %) |
Aug 05 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 4,997 | 44,973 | 134,054 | 129.1 K to 134.1 K (+3.87 %) |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 2.30 | 4,812 | 11,068 | 4,812 | |
Apr 15 2008 | NRGN | NEUROGEN CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 0.00 | 4,812 | 0 | 4,812 | |
May 16 2008 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Option Exercise | C | 0.00 | 8 | 0 | 0 | |
May 16 2008 | IBPI | Ardea Biosciences, ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | C | 0.00 | 42,089 | 0 | 95,646 | 53.6 K to 95.6 K (+78.59 %) |
Mar 17 2008 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 8.67 | 17 | 147 | 74,977 | 75 K to 75 K (+0.02 %) |
Mar 17 2008 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 8.69 | 237 | 2,060 | 74,960 | 74.7 K to 75 K (+0.32 %) |
Jan 10 2008 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 8.95 | 1,471 | 13,163 | 74,723 | 73.3 K to 74.7 K (+2.01 %) |
Jan 10 2008 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 8.76 | 2,153 | 18,853 | 73,252 | 71.1 K to 73.3 K (+3.03 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.06 | 185 | 1,490 | 365,645 | 365.5 K to 365.6 K (+0.05 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.08 | 398 | 3,217 | 365,460 | 365.1 K to 365.5 K (+0.11 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.93 | 181 | 1,434 | 365,062 | 364.9 K to 365.1 K (+0.05 %) |
Mar 14 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 7.98 | 55 | 439 | 364,881 | 364.8 K to 364.9 K (+0.02 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.06 | 723 | 6,547 | 364,826 | 364.1 K to 364.8 K (+0.20 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.94 | 6 | 54 | 364,103 | 364.1 K to 364.1 K (0.00 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 332 | 2,989 | 364,097 | 363.8 K to 364.1 K (+0.09 %) |
Feb 11 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 97 | 873 | 363,765 | 363.7 K to 363.8 K (+0.03 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.03 | 1,915 | 17,288 | 363,668 | 361.8 K to 363.7 K (+0.53 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.78 | 1,344 | 11,797 | 361,753 | 360.4 K to 361.8 K (+0.37 %) |
Jan 23 2008 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.00 | 39,911 | 359,199 | 360,409 | 320.5 K to 360.4 K (+12.45 %) |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 355,000 | 3,982,568 | 375,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 17,000 | 190,715 | 20,000 | |
Jan 31 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | P | 11.22 | 3,000 | 33,656 | 3,000 | |
Jan 24 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.62 | 4 | 42 | 129,057 | 129.1 K to 129.1 K (0.00 %) |
Jan 16 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.99 | 723 | 7,944 | 129,053 | 128.3 K to 129.1 K (+0.56 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.94 | 641 | 7,010 | 128,330 | 127.7 K to 128.3 K (+0.50 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 11.01 | 26 | 286 | 127,689 | 127.7 K to 127.7 K (+0.02 %) |
Jan 11 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.94 | 1,892 | 20,704 | 127,663 | 125.8 K to 127.7 K (+1.50 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.00 | 504 | 5,038 | 125,771 | 125.3 K to 125.8 K (+0.40 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.89 | 9,576 | 104,321 | 125,267 | 115.7 K to 125.3 K (+8.28 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.48 | 4,432 | 42,020 | 115,691 | 111.3 K to 115.7 K (+3.98 %) |
Jan 08 2008 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.47 | 6,237 | 59,043 | 111,259 | 105 K to 111.3 K (+5.94 %) |
Feb 27 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.00 | 425 | 2,550 | 99,878 | 99.5 K to 99.9 K (+0.43 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.20 | 298 | 1,848 | 99,453 | 99.2 K to 99.5 K (+0.30 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 5.90 | 319 | 1,882 | 99,155 | 98.8 K to 99.2 K (+0.32 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.50 | 453 | 2,944 | 98,836 | 98.4 K to 98.8 K (+0.46 %) |
Feb 21 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.75 | 450 | 3,039 | 98,383 | 97.9 K to 98.4 K (+0.46 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.95 | 392 | 2,725 | 97,933 | 97.5 K to 97.9 K (+0.40 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.92 | 11 | 76 | 97,541 | 97.5 K to 97.5 K (+0.01 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.15 | 88 | 629 | 97,530 | 97.4 K to 97.5 K (+0.09 %) |
Jan 23 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.22 | 102 | 736 | 97,442 | 97.3 K to 97.4 K (+0.10 %) |
Jan 17 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.50 | 399 | 2,993 | 97,340 | 96.9 K to 97.3 K (+0.41 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.41 | 1,871 | 13,873 | 96,941 | 95.1 K to 96.9 K (+1.97 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.47 | 792 | 5,919 | 95,070 | 94.3 K to 95.1 K (+0.84 %) |
Jan 14 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.47 | 1,667 | 12,451 | 94,278 | 92.6 K to 94.3 K (+1.80 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.96 | 898 | 6,250 | 92,611 | 91.7 K to 92.6 K (+0.98 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.21 | 2,879 | 20,762 | 91,713 | 88.8 K to 91.7 K (+3.24 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.85 | 1,439 | 9,857 | 88,834 | 87.4 K to 88.8 K (+1.65 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.37 | 18 | 115 | 87,395 | 87.4 K to 87.4 K (+0.02 %) |
Jan 09 2008 | ALTH | ALLOS THERAPEUTICS ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 6.37 | 3 | 19 | 87,377 | 87.4 K to 87.4 K (0.00 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.63 | 700 | 5,342 | 71,099 | 70.4 K to 71.1 K (+0.99 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.43 | 1,229 | 9,136 | 70,399 | 69.2 K to 70.4 K (+1.78 %) |
Nov 09 2007 | VPHM | VIROPHARMA INC | Baker / Tisch Capital (GP), LL ... | 10% Owner | Buy | P | 7.27 | 983 | 7,151 | 69,170 | 68.2 K to 69.2 K (+1.44 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.61 | 1,862 | 19,752 | 105,022 | 103.2 K to 105 K (+1.80 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.58 | 1,124 | 11,896 | 103,160 | 102 K to 103.2 K (+1.10 %) |
Dec 19 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.60 | 1,974 | 20,915 | 102,036 | 100.1 K to 102 K (+1.97 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 10.38 | 3,560 | 36,970 | 100,062 | 96.5 K to 100.1 K (+3.69 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.85 | 1,392 | 13,712 | 96,502 | 95.1 K to 96.5 K (+1.46 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.87 | 1,832 | 18,086 | 95,110 | 93.3 K to 95.1 K (+1.96 %) |
Dec 12 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 9.54 | 2,265 | 21,618 | 93,278 | 91 K to 93.3 K (+2.49 %) |
Dec 06 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.98 | 1,139 | 10,230 | 91,013 | 89.9 K to 91 K (+1.27 %) |
Nov 21 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.22 | 318 | 2,615 | 89,874 | 89.6 K to 89.9 K (+0.36 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.25 | 308 | 2,541 | 88,503 | 88.2 K to 88.5 K (+0.35 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.26 | 70 | 578 | 88,195 | 88.1 K to 88.2 K (+0.08 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.22 | 51 | 419 | 88,125 | 88.1 K to 88.1 K (+0.06 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.30 | 82 | 681 | 88,074 | 88 K to 88.1 K (+0.09 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.00 | 39 | 312 | 87,992 | 88 K to 88 K (+0.04 %) |
Nov 13 2007 | INCY | INCYTE CORP | Baker / Tisch Capital (GP), LL ... | Director | Buy | P | 8.23 | 75 | 618 | 87,953 | 87.9 K to 88 K (+0.09 %) |